Placebo control, double blind, randomized clinical trial to assess the effecacy of Ulinastatin for postoperative incidence rate of complications following pancreaticoduodenectomy

Trial Profile

Placebo control, double blind, randomized clinical trial to assess the effecacy of Ulinastatin for postoperative incidence rate of complications following pancreaticoduodenectomy

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Feb 2017

At a glance

  • Drugs Ulinastatin (Primary)
  • Indications Pancreatitis
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Feb 2017 New source identified and integrated (ChiCTR-TRC-12002160 Chinese Clinical Trial Register).
    • 23 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top